Clinical Trial Update: Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany

View source ↗

Summary

A real-world observational study evaluating dapagliflozin use in heart failure patients in Germany, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Diseases, Cardiovascular Diseases | Status: ACTIVE_NOT_RECRUITING